Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.
Sanofi still faces about 20,000 lawsuits over Zantac in Delaware state court.
That judge concluded that the opinions of the plaintiffs’ expert witnesses that Zantac can cause cancer were not supported by sound science.
“We are pushing forward aggressively against GSK and Boehringer Ingelheim and are preparing for multiple trials in California state court this year,” Moore said.
Lawsuits began piling up from people who said they developed cancer after taking Zantac.
Persons:
Sanofi, “ Sanofi, Boehringer, Boehringer Ingelheim, Jennifer Moore, Brent Wisner, ” Moore, Zantac, ranitidine
Organizations:
Court, Sanofi, GSK, Pfizer, Boehringer, US Food and Drug Administration
Locations:
Delaware, Zantac, Wilmington, Florida, California